Journal article · 2025
A feasibility study for personalized phage therapy against drug-resistant bacteria in Japan
Journal of Infection and Chemotherapy, 31(9), 102770 · Published 15 July 2025 · DOI 10.1016/j.jiac.2025.102770
In brief
“A feasibility study for personalized phage therapy against drug-resistant bacteria in Japan” is a 2025 journal article by Kayoko Hayakawa and 24 co-authors, published in Journal of Infection and Chemotherapy. OpenAlex counts 4 citations as of 15 November 2026, which puts it in the top 7% of works published in 2025 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.
- Citations
- 4
- Most cited in
- 2025 (2)
- Field-weighted impact
- 1.20
- References
- 8
- Authors
- 25
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Hayakawa, K., Kiga, K., Ojima, S., Chihara, K., Tamura, A., Yamashita, W., Nakamura, T., Azam, A. H., Nie, W., Sato, Y., Sakai, J., Kondo, K., Takahashi, Y., Watashi, K., Saito, S., Moriyama, Y., Kurokawa, M., Mezaki, K., Ohashi, H., . . . Ohmagari, N. (2025). A feasibility study for personalized phage therapy against drug-resistant bacteria in Japan. Journal of Infection and Chemotherapy, 31(9), 102770. https://doi.org/10.1016/j.jiac.2025.102770
MLA 9
Hayakawa, Kayoko, et al. “A feasibility study for personalized phage therapy against drug-resistant bacteria in Japan.” Journal of Infection and Chemotherapy, vol. 31, no. 9, 2025, p. 102770. https://doi.org/10.1016/j.jiac.2025.102770.
Chicago
Hayakawa, Kayoko, Kotaro Kiga, Shinjiro Ojima, Kotaro Chihara, Azumi Tamura, Wakana Yamashita, Tomohiro Nakamura, et al. 2025. “A feasibility study for personalized phage therapy against drug-resistant bacteria in Japan.” Journal of Infection and Chemotherapy 31 (9): 102770. https://doi.org/10.1016/j.jiac.2025.102770.
Harvard
Hayakawa, K. et al. (2025) ‘A feasibility study for personalized phage therapy against drug-resistant bacteria in Japan’, Journal of Infection and Chemotherapy, 31(9), p. 102770. doi:10.1016/j.jiac.2025.102770.
IEEE
K. Hayakawa et al., “A feasibility study for personalized phage therapy against drug-resistant bacteria in Japan,” Journal of Infection and Chemotherapy, vol. 31, no. 9, p. 102770, 2025, doi: 10.1016/j.jiac.2025.102770.
BibTeX
@article{hayakawa2025feasibility,
title = {{A feasibility study for personalized phage therapy against drug-resistant bacteria in Japan}},
author = {Hayakawa, Kayoko and Kiga, Kotaro and Ojima, Shinjiro and Chihara, Kotaro and Tamura, Azumi and Yamashita, Wakana and Nakamura, Tomohiro and Azam, Aa Haeruman and Nie, Wenhan and Sato, Yuta and Sakai, Jun and Kondo, Kohei and Takahashi, Yoshimasa and Watashi, Koichi and Saito, Sho and Moriyama, Yuki and Kurokawa, Masami and Mezaki, Kazuhisa and Ohashi, Hirotake and Ohashi, Yasukata and Nishimura, Takahiro and Shinohara, Koh and Yamagishi, Yoshiaki and Doi, Yohei and Ohmagari, Norio},
journal = {Journal of Infection and Chemotherapy},
year = {2025},
volume = {31},
number = {9},
pages = {102770},
doi = {10.1016/j.jiac.2025.102770},
url = {https://doi.org/10.1016/j.jiac.2025.102770}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Life Sciences › Immunology and Microbiology › Virology › Bacteriophages and microbial interactions
- personalized phage therapy
- bacteriophages
- drug-resistant bacteria
- antimicrobial resistance
- methicillin-resistant Staphylococcus aureus
- carbapenem-resistant Pseudomonas aeruginosa
- nontuberculous mycobacteria
- Mycobacterium avium
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Hayakawa, K., Kiga, K., Ojima, S., Chihara, K., Tamura, A., Yamashita, W., Nakamura, T., Azam, A. H., Nie, W., Sato, Y., Sakai, J., Kondo, K., Takahashi, Y., Watashi, K., Saito, S., Moriyama, Y., Kurokawa, M., Mezaki, K., Ohashi, H., . . . Ohmagari, N. (2025). A feasibility study for personalized phage therapy against drug-resistant bacteria in Japan. Journal of Infection and Chemotherapy, 31(9), 102770. https://doi.org/10.1016/j.jiac.2025.102770
How many times has this paper been cited?
4 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.
Who wrote this paper?
Kayoko Hayakawa, Kotaro Kiga, Shinjiro Ojima, Kotaro Chihara, Azumi Tamura, Wakana Yamashita, Tomohiro Nakamura, Aa Haeruman Azam, Wenhan Nie, Yuta Sato, Jun Sakai, Kohei Kondo and 13 more.
What is the DOI of this paper?
10.1016/j.jiac.2025.102770. The permanent link is https://doi.org/10.1016/j.jiac.2025.102770.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.